Imiglucerase and its use for the treatment of Gaucher's disease

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.9, Iss.11, 2008-08, pp. : 1987-2000

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alglucerase/imiglucerase withdrawal: Skeletal (first report) and haematological manifestations, organomegaly and growth delays in children with type 1 Gaucher's disease: 4 case reports

Reactions Weekly, Vol. 1, Iss. 1173, 2007-01 ,pp. : 4-5

Adis International

Access to resources Recommend Favorite

Recent Advances in Treatment Approaches to Gaucher Disease

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 6, 2011-06 ,pp. : 854-860

Bentham Science Publishers

Access to resources Recommend Favorite

Cabergoline: A Review of its Use in the Treatment of Parkinson's Disease

By Monique P. Curran Caroline M. Perry

Drugs, Vol. 64, Iss. 18, 2004-01 ,pp. : 2125-2141

Adis International

Access to resources Recommend Favorite

Rotigotine Transdermal Patch: A Review of its Use in the Treatment of Parkinson's Disease

By Sanford Mark Scott Lesley J.

CNS Drugs, Vol. 25, Iss. 8, 2011-08 ,pp. : 699-719

Adis International

Access to resources Recommend Favorite

The Sirolimus-Eluting Stent: A Review of Its Use in the Treatment of Coronary Artery Disease

By McKeage K. Murdoch D. Goa K.L.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 3, 2003-01 ,pp. : 211-230

Adis International

Access to resources Recommend Favorite